Navigate BioPharma Services, Inc., a Novartis subsidiary

3 articles about Navigate BioPharma Services, Inc., a Novartis subsidiary

• Navigate BioPharma Services, Inc. in Collaboration with Partners Validate Analytical Assay for Acute Myeloid Leukemia Measurable Residual Disease (AML-MRD) Assessment

  3/15/2024

  Navigate BioPharma Services, Inc. in Collaboration with Partners Validate Analytical Assay for Acute Myeloid Leukemia Measurable Residual Disease (AML-MRD) Assessment.

• 

  Optimizing Biomarker Assays to Bridge the Clinical Trial Participation Gap

  11/1/2023

  High multiplexed patient-centric assays could reduce patient burden

• Navigate BioPharma Services, Inc. Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development

  9/7/2023

  Navigate BioPharma Services, Inc. announces a strategic collaboration with BD (Becton, Dickinson and Company) to explore opportunities to develop and commercialize flow cytometry-based companion diagnostics and tools for clinical decisions.